NCT07803445

Brief Summary

This study looks at whether adding ozone gel to ultrasound treatment (a method called phonophoresis) helps chronic leg wounds caused by poor vein function heal better than ultrasound or ozone gel used alone. Chronic venous leg ulcers are open sores on the lower leg that happen when the veins cannot properly return blood to the heart. They are slow to heal and can affect a person's daily life, comfort, and sleep. Ultrasound therapy is sometimes used to help push medicated gels deeper into the skin, a technique called phonophoresis. Ozone gel is a topical product that may help fight infection and support tissue repair. This study will compare four approaches to see which combination works best alongside standard wound care. Eighty men and women between 40 and 65 years old with a venous leg ulcer that has lasted more than 6 weeks will be randomly placed into one of four groups. All participants will continue to receive standard wound care (cleaning, dressing, and compression) throughout the study. Depending on their group, participants will also receive: ultrasound combined with ozone gel applied together, ultrasound followed by ozone gel applied separately, ultrasound alone, or ozone gel alone. Treatment will be given three times a week for six weeks. Researchers will measure wound size, wound depth, and quality of life before treatment and again after six weeks to see which approach helps the wounds heal best.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 31, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 3, 2026

Completed
Last Updated

September 3, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

August 31, 2026

Last Update Submit

August 31, 2026

Conditions

Keywords

Ozone TherapyOzonated GelPhonophoresisUltrasound TherapyWound HealingVenous Leg UlcerChronic Wound

Outcome Measures

Primary Outcomes (1)

  • Change in Wound Surface Area

    Wound length, width, and surface area assessed using the ImitoMeasure smartphone-based digital planimetry application, with an adhesive calibration marker placed adjacent to the wound.

    Baseline and 6 weeks post-treatment

Secondary Outcomes (2)

  • Change in Wound Volume

    Baseline (pre-treatment) and 6 weeks (post-treatment)

  • Change in Wound-Related Quality of Life

    Baseline (pre-treatment) and 6 weeks (post-treatment)

Study Arms (4)

Ozonated Gel Phonophoresis

EXPERIMENTAL

Participants received ozonated gel phonophoresis (ultrasound at 0.5 W/cm², 1 MHz frequency, pulsed mode with 20% duty cycle, applied for 5-10 minutes depending on ulcer size, using ozonated gel as the coupling medium), three sessions per week for six weeks, in addition to conventional medical treatment and traditional wound care (cleansing, dressing, compression, repositioning, use of support surfaces, exercise, and medication).

Combination Product: Ozonated Gel Phonophoresis

Ultrasound Followed by Topical Ozonated Gel

ACTIVE COMPARATOR

Participants received ultrasound therapy followed by separate topical application of ozonated gel, three sessions per week for six weeks, in addition to conventional medical treatment and traditional wound care.

Device: Ultrasound TherapyOther: Ozonated Gel

Ultrasound Alone

ACTIVE COMPARATOR

Participants received ultrasound therapy alone (0.5 W/cm², 1 MHz, pulsed pattern), in addition to conventional medical treatment and traditional wound care.

Device: Ultrasound TherapyOther: Conventional Wound Care

Topical Ozonated Gel Alone

ACTIVE COMPARATOR

Participants received topical ozonated gel treatment only.

Combination Product: Ozonated Gel PhonophoresisDevice: Ultrasound TherapyOther: Ozonated Gel

Interventions

Ozonated Gel PhonophoresisCOMBINATION_PRODUCT

Ultrasound-mediated delivery of ozonated gel (medical-grade ozone/oxygen mixture in olive oil base) at 0.5 W/cm², 1 MHz, pulsed 20% duty cycle. Assigned to Ozonated Gel Phonophoresis (Arm 1)

Ozonated Gel PhonophoresisTopical Ozonated Gel Alone

Therapeutic ultrasound at 0.5 W/cm², 1 MHz, pulsed mode. assigned to: Ultrasound Followed by Topical Ozonated Gel (Arm 2), Ultrasound Alone (Arm 3)

Topical Ozonated Gel AloneUltrasound AloneUltrasound Followed by Topical Ozonated Gel

Topical gel composed of medical-grade ozone (0.25% ozone / 99.75% oxygen mixture) in an olive oil base. assigned to: Ultrasound Followed by Topical Ozonated Gel (Arm 2), Topical Ozonated Gel Alone (Arm 4)

Topical Ozonated Gel AloneUltrasound Followed by Topical Ozonated Gel

Standard care including ulcer cleansing, dressing, compression, repositioning, use of support surfaces, exercise, and medication. it's assigned to: All four arms

Ultrasound Alone

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age range between 40 and 65 years
  • Male and female patients
  • Diagnosed with venous ulceration based on clinical investigation
  • Venous ulcer presenting for more than 6 weeks
  • Willing and able to provide informed consent
  • Available for pre-treatment and post-treatment assessment

You may not qualify if:

  • \- Ulcer caused by conditions such as arterial disease
  • Diabetes mellitus
  • Active malignancy
  • Psychological instability
  • Skin diseases such as eczema
  • Life-threatening disorders, including renal failure, myocardial infarction, and autoimmune diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, Giza Governorate, Egypt

Location

MeSH Terms

Conditions

Varicose Ulcer

Interventions

Ultrasonic Therapy

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

DiathermyHyperthermia, InducedTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer Assistant at October university for modern arts and sciencs

Study Record Dates

First Submitted

August 31, 2026

First Posted

September 3, 2026

Study Start

October 1, 2025

Primary Completion

August 1, 2026

Study Completion

August 1, 2026

Last Updated

September 3, 2026

Record last verified: 2026-08

Locations